P7C3-A-20

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameP7C3-A-20
Drug Alias NameP7C3-A-20P7C3-A20P-7-C-3-A-20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical Center
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A